Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

https://clinicaltrials.gov/ct2/show/NCT02912559

Alliance A021502
Cancer
Peter Bushunow, MD
Enrolling
Rachel O’Loughlin, RN BSN
(585) 747-4555